Literature DB >> 25398718

Mechanisms linking connexin mutations to human diseases.

John J Kelly1, Jamie Simek, Dale W Laird.   

Abstract

Ubiquitously expressed connexins are tetra-spanning transmembrane proteins that form intercellular gap junction channels or cell surface hemichannels. Connexins share similar topology but no sequence homology with mammalian pannexins and CALHM1 (calcium homeostasis modulator 1), which are also large-pore transmembrane channels. Of these three channel types, clinical evidence and gene sequence analysis to date have revealed that inherited human diseases are only associated with mutations in the connexin gene family. Connexin-linked diseases often present at birth or early in life and range from mild developmental abnormalities to severe organ failure such as hearing loss. Inherited connexin gene mutations can manifest as a disease by causing anomalies or defects in connexin oligomerization, folding, ability to pass quality control mechanisms or unexpected gain- or loss-of-function. This review provides examples of the way that various connexin gene mutations can cause disease via a wide range of molecular mechanisms. We also reflect on exciting strategies being explored in the connexin field and beyond with a view of translating their findings into potential connexin-disease therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398718     DOI: 10.1007/s00441-014-2024-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  40 in total

1.  Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.

Authors:  Megan C Moorer; Carla Hebert; Ryan E Tomlinson; Shama R Iyer; Max Chason; Joseph P Stains
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

2.  Junctions in human health and inherited disease.

Authors:  Spiro Getsios; David P Kelsell; Andy Forge
Journal:  Cell Tissue Res       Date:  2015-04-11       Impact factor: 5.249

3.  The double life of connexin channels: single is a treat.

Authors:  Roberto Bruzzone
Journal:  J Invest Dermatol       Date:  2015-04       Impact factor: 8.551

4.  Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.

Authors:  Eric R Press; Qing Shao; John J Kelly; Katrina Chin; Anton Alaga; Dale W Laird
Journal:  J Biol Chem       Date:  2017-04-20       Impact factor: 5.157

Review 5.  Gap Junctions and Wnt Signaling in the Mammary Gland: a Cross-Talk?

Authors:  Sabreen F Fostok; Mirvat El-Sibai; Marwan El-Sabban; Rabih S Talhouk
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

6.  Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.

Authors:  Xinyue Zhang; Chengyuan Li; Stephen C Fowler; Zheng Zhang; Brian S J Blagg; Rick T Dobrowsky
Journal:  ACS Chem Neurosci       Date:  2017-11-09       Impact factor: 4.418

Review 7.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

Review 8.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 9.  Interactions of Pannexin1 channels with purinergic and NMDA receptor channels.

Authors:  Shuo Li; Ivana Bjelobaba; Stanko S Stojilkovic
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-04       Impact factor: 3.747

10.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.